TABLE 3

Performance of PET Parameters in Predicting pCR Early in All 78 TNBC Patients

SUV_max	AUC	95% confidence interval
At PET₁
Tumor	0.70	0.57–0.81
Axilla (n = 58)	0.60	0.45–0.74
Target^*	0.62	0.49–0.74
Tumor + axilla^†	0.71	0.59–0.82
At PET₂
Tumor	0.67	0.55–0.79
Axilla (n = 58)	0.76	0.62–0.88
Target	0.72	0.6–0.83
Tumor + axilla	0.76	0.65–0.87
Difference (ΔSUV_max %)
Tumor	0.86	0.77–0.93
Axilla (n = 58)	0.69	0.54–0.84
Target	0.82	0.72–0.9
Tumor + axilla	0.86	0.77–0.93

↵* Site with highest baseline SUV_max (either breast tumor or axillary lymph node).
↵† Logistic regression analysis combining tumor and axilla measurements.